138 related articles for article (PubMed ID: 16585428)
21. Child psychopharmacology: politics versus science.
Levy F
Aust N Z J Psychiatry; 2013 Oct; 47(10):961. PubMed ID: 23888073
[No Abstract] [Full Text] [Related]
22. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
[TBL] [Abstract][Full Text] [Related]
23. With the recent Food and Drug Administration (FDA) Advisory Committee's recommendation to put a black box warning on stimulants, the government has joined the media in raising alarm about the medical treatment of attention-deficit disorder.
Hackford R
J Dev Behav Pediatr; 2006 Apr; 27(2):179. PubMed ID: 16682886
[No Abstract] [Full Text] [Related]
24. Consequences of ADHD medication use for children's outcomes.
Dalsgaard S; Nielsen HS; Simonsen M
J Health Econ; 2014 Sep; 37():137-51. PubMed ID: 24997381
[TBL] [Abstract][Full Text] [Related]
25. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
[TBL] [Abstract][Full Text] [Related]
26. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.
Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L
BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
28. Time for some reason in the ADHD debate.
Starling J
Aust N Z J Psychiatry; 2013 Oct; 47(10):958-9. PubMed ID: 23888075
[No Abstract] [Full Text] [Related]
29. Response to Whitely: a caution from the coalface.
Levy F
Aust N Z J Psychiatry; 2012 May; 46(5):404-6. PubMed ID: 22535290
[No Abstract] [Full Text] [Related]
30. Prescription of methylphenidate to children and youth, 1990-1996.
Miller AR; Lalonde CE; McGrail KM; Armstrong RW
CMAJ; 2001 Nov; 165(11):1489-94. PubMed ID: 11762572
[TBL] [Abstract][Full Text] [Related]
31. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.
Schubert I; Köster I; Lehmkuhl G
Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775
[TBL] [Abstract][Full Text] [Related]
32. Politics vs practice: commentary on the ADHD debate.
Levy F
Aust N Z J Psychiatry; 2013 Jan; 47(1):89-91. PubMed ID: 23293313
[No Abstract] [Full Text] [Related]
33. [Time Trends in the Frequencies of ADHD and Stimulant Medication].
Steinhausen HC; Döpfner M; Schubert I
Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):275-84. PubMed ID: 27434688
[TBL] [Abstract][Full Text] [Related]
34. ADHD debate clouded by preconceptions and undisclosed conflicts of interest.
Whitely M
Aust N Z J Psychiatry; 2013 Oct; 47(10):956-8. PubMed ID: 23888076
[No Abstract] [Full Text] [Related]
35. The ADHD debate: to bury national guidelines or to praise them?
Paterson R
Aust N Z J Psychiatry; 2013 Oct; 47(10):959-60. PubMed ID: 23888074
[No Abstract] [Full Text] [Related]
36. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
[TBL] [Abstract][Full Text] [Related]
37. Commentary on Levy (2012) politics vs practice: withdrawal of the draft NHMRC ADHD guidelines.
Starling J
Aust N Z J Psychiatry; 2013 Jan; 47(1):91-2. PubMed ID: 23293314
[No Abstract] [Full Text] [Related]
38. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
[TBL] [Abstract][Full Text] [Related]
39. Sudden Increases in U.S. Stimulant Prescribing: Alarming or Not?
Sibley MH; Faraone SV; Nigg JT; Surman CBH
J Atten Disord; 2023 Apr; 27(6):571-574. PubMed ID: 36946184
[No Abstract] [Full Text] [Related]
40. Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants.
Leslie LK; Rodday AM; Saunders TS; Cohen JT; Wong JB; Sheldrick RC; Parsons SK
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):375-84. PubMed ID: 23083024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
